CDRD also provides access to the following platforms via established external partnerships:
The Metabolomics Innovation Centre (TMIC), led by Dr. David Wishart and located at the University of Alberta has a unique combination of infrastructure and personnel to perform a wide range of cutting-edge metabolomic studies for clinical trials research, biomedical studies, bioproducts studies, nutrient profiling and environmental testing. It is supported by a team of lab managers, NMR spectroscopists, mass spectrometrists, chemists, computer scientists, statisticians and bioinformaticians, and is capable of identifying and quantifying up to 2,000 different chemicals from certain biological samples. This is approximately 5X more comprehensive than any other service currently available.
CDRD also has access to proteomics expertise and facilities at the University of Victoria’s Genome BC Proteomics Centre, led by Dr. Christoph Borchers. The mandate of the Centre is to provide exceptional service and support for proteomics research in the areas of protein identification and characterization, and quantitative proteomics for biomarker discovery and validation.
The Centre for High-throughput Biology (CHiBi), led by Dr. Steve Withers was established in 2008 with the aim of placing British Columbia and Canada as leaders in the emerging fields of applied genomics and synthetic biology by bringing together areas of molecular biology, genetics, computational biology and micro biology in support of the physical and life sciences while capitalizing on high-throughput genomics, proteomics, and bioinformatics expertise that exist at the University of British Columbia. Despite its relatively short existence, CHiBi is rapidly emerging as a leading centre of excellence in the development and application of high-throughput methods to a variety of biological systems, as well as in the training of the next generation of researchers in this area. CHiBi`s multidisciplinary group of investigators is located in the Networks of Centres of Excellence (NCE) and conjoined Michael Smith Laboratories buildings at the centre of the UBC Point Grey campus.
The BC Cancer Agency’s Michael Smith Genome Sciences Centre, led by Dr. Marco Marra, is a leading international centre for genomics and bioinformatics research. Its mandate is to advance knowledge about cancer and other diseases, to improve human health through disease prevention, diagnosis and therapeutic approaches, and to realize the social and economic benefits of genomics research. The world-class scientific team at the Genome Sciences Centre has played a major role in advancing the fields of genomics and bioinformatics, and their scientists have been involved in many collaborative sequencing projects within Canada and around the world.